Physician profile
Shaf B Holden
NPI 1518161397
$32,382.85
in general payments reported to CMS, 2019-2025
38 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,251 · 2021: $1,108 · 2022: $3,046 · 2023: $2,866 · 2024: $5,330 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,876 · Travel and Lodging: $2,437 · Consulting Fee: $1,995 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,876.23 |
| Travel and Lodging | $2,436.60 |
| Consulting Fee | $1,995.00 |
| Education | $180.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16,971.90 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Hemosphere |
| Atricure, INC. | $5,384.39 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Baxter Healthcare | $4,085.03 | 2021-2025 | Floseal, Preveleak, Coseal |
| Medtronic Vascular, INC. | $1,448.34 | 2019-2020 | |
| Medtronic, INC. | $1,253.70 | 2021-2025 | Penditure, Mosaic, Corevalve Evolut R |
| Abiomed | $937.62 | 2021-2025 | Impella |
| Zimmer Biomet Holdings, INC. | $508.49 | 2020-2024 | Sternalock |
| Abbott Laboratories | $299.36 | 2023-2024 | Epic, Navitor |
| Lsi Solutions INC | $228.95 | 2022-2023 | Cor Knot |
| Artivion, INC. | $207.81 | 2019-2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Boston Scientific Corporation | $158.01 | 2019-2020 | |
| Hemosonics LLC | $150.52 | 2021-2022 | |
| Cook Medical LLC | $58.86 | 2023-2024 | Cook |
| Olympus America INC. | $50.27 | 2019-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $45.56 | 2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $44.52 | 2019-2023 | |
| Kls-Martin L.P. | $38.98 | 2023 | |
| Janssen Pharmaceuticals, INC | $37.75 | 2019 | |
| La Jolla Pharmaceutical Company | $37.02 | 2025 | Zevtera, Giapreza |
| E.R. Squibb & Sons, L.L.C. | $34.92 | 2022-2023 | Opdivo |
| Sanofi-Aventis U.S. LLC | $34.81 | 2019 | |
| Angiodynamics, INC. | $33.40 | 2025 | Angiovac |
| Tela Bio, INC. | $32.64 | 2022 | |
| Becton, Dickinson and Company | $30.61 | 2025 | Hemosphere |
| Convatec INC. | $28.93 | 2024 | |
| Cook Biotech Incorporated | $27.21 | 2023 | Biodesign |
| Chiesi USA, INC. | $26.22 | 2019-2021 | |
| Intuitive Surgical, INC. | $24.44 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.53 | 2019-2020 | |
| Prime Surgical, LLC | $20.97 | 2025 | |
| Livanova USA, INC. | $19.98 | 2019 | |
| Amgen INC. | $15.66 | 2019 | |
| Ethicon US, LLC | $15.32 | 2024 | Surgicel Nu-Knit, Evarrest |
| Lemaitre Vascular, INC. | $15.08 | 2023 | Tyke, Patch, Pledget and Intracardiac |
| Medela LLC | $13.95 | 2022 | |
| Kci USA, INC. | $13.01 | 2019 | |
| Sanara Medtech INC. | $12.78 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaf Holden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.